Genitourinary Cancer

Top Story

VIDEO: Physicians should take special considerations for metastatic renal cell carcinoma management

November 17, 2017

MIAMI Saby George, MD, FACS, offered background in special considerations that should be taken when treating patients with metastatic renal cell carcinoma at the International Kidney Cancer Symposium.

FDA News

FDA approves Sutent to reduce risk for recurrent kidney cancer

November 16, 2017
The FDA today approved sunitinib malate for the adjuvant treatment of adults at high risk for recurrent renal cell carcinoma following nephrectomy. “This is the…
Meeting News

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

November 16, 2017
WASHINGTON — When diagnosed with Hodgkin lymphoma at…
FDA News

FDA authorizes IMPACT test to rapidly identify cancer mutations

November 15, 2017
The FDA today authorized Integrated Mutation Profiling of Actionable Cancer Targets, or IMPACT, an in vitro diagnostic test that uses next-generation sequencing to…
More Headlines »
CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Video
Meeting News

VIDEO: Stereotactic radiotherapy preferred for brain metastases from renal cell carcinoma

November 5, 2017
More »
Resource Centers

CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »